Effector function of anti-pyroglutamate-3 Aβ antibodies affects cognitive benefit, glial activation and amyloid clearance in Alzheimer’s-like mice

Abstract Background Pyroglutamate-3 Aβ (pGlu-3 Aβ) is an N-terminally truncated and post-translationally modified Aβ species found in Alzheimer’s disease (AD) brain. Its increased peptide aggregation propensity and toxicity make it an attractive emerging treatment strategy for AD. We address the que...

Descripció completa

Dades bibliogràfiques

Autors principals:	Helen Crehan, Bin Liu, Martin Kleinschmidt, Jens-Ulrich Rahfeld, Kevin X. Le, Barbara J. Caldarone, Jeffrey L. Frost, Thore Hettmann, Birgit Hutter-Paier, Brian O’Nuallain, Mi-Ae Park, Marcelo F. DiCarli, Inge Lues, Stephan Schilling, Cynthia A. Lemere
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2020-01-01
Col·lecció:	Alzheimer’s Research & Therapy
Matèries:	Pyroglutamate-3 amyloid-β Immunotherapy APPSWE/PS1ΔE9 Phagocytosis Microhemorrhage microPET
Accés en línia:	https://doi.org/10.1186/s13195-019-0579-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!